SXTP Earnings 60 DEGREES PHARMACEUTICALS, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -1.28 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -11.73 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -4.65 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.79 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -6.25 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -74.17 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -21.74 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -21.41 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | 1.83 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -59.18 | 2025-03-27 | 10-K |
| Q3 2024 | 2023-09-30 | -6.59 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -30.44 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.13 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -2.61 | 2024-04-01 | 10-K |
| Q3 2023 | 2022-09-30 | -1.92 | 2023-11-20 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.31 | 2023-08-25 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.